Prospective assesment of drug interactions in hospitalized patients using a computer programme;Evaluación prospectiva de interacciones entre medicamentos en pacientes ingresados mediante una aplicación informática

Farmacia Hospitalaria

Volumn 31, Issue 2, 2007, Pages 93-100

  Peral Aguirregoitia, Javier ^a   Lertxundi Etxebarria, U ^a   Martinez Bengoechea M J ^a   Mora Atorrasagasti, O ^a   Franco Lamela, E ^a   Gabilondo Zelaia, I ^a  

^a HOSPITAL DE GALDAKAO   (Spain)

Author keywords

Adverse drug event; Drug drug interaction; Pharmacotherapy; Unitary doses

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ALLOPURINOL; ALPRAZOLAM; ATAZANAVIR; ATORVASTATIN; CAPTOPRIL; CARBAMAZEPINE; CIPROFLOXACIN; CLARITHROMYCIN; CYCLOSPORIN A; DANAZOL; DILTIAZEM; FLUCONAZOLE; GEMFIBROZIL; IRON; LEVOTHYROXINE; LINEZOLID; METRONIDAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NORADRENALIN; OMEPRAZOLE; POTASSIUM; REPAGLINIDE; SIMVASTATIN; SPIRONOLACTONE; THEOPHYLLINE; TRIAMTERENE; UNINDEXED DRUG; VERAPAMIL;

ADOLESCENT; ADULT; ADVERSE OUTCOME; AGE DISTRIBUTION; AGED; ARTICLE; AUTOMATION; CHILD; COMPUTER PROGRAM; DRUG INTERACTION; DRUG MONITORING; DRUG USE; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; PATIENT MONITORING; PHARMACIST; PHYSICIAN; PRESCRIPTION; SEX RATIO; STATISTICAL ANALYSIS; VALIDATION STUDY;

EID: 34347366415     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-6343(07)75719-7     Document Type: Article

References (31)

1. Hamilton RA, Briceland LL, Andritz MH. Frequency of hospitalization after exposure to known drug-drug interactions in a Medicaid population. Pharmacother 1998; 18: 1112-20.
2. Björkman IK, Fastbom J, Schmidt IK, Bernsten CB and the PEER group. Drug-drug interactions in the elderly. Ann Pharmacother 2002; 36: 1675-81.
3. Alonso Hernández P, Otero López MJ, Maderuelo Fernández JA. Ingresos hospitalarios causados por medicamentos: incidencia, características y coste. Farm Hosp 2002; 26: 77-89.
4. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA 1997; 277: 301-6.
5. Malone DC, Abarca J, Hansten PD, Grizzle AJ, Armstrong EP, Van Berger RC, et al. Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions. J Am Pharm Assoc 2004; 44: 142-51.
6. Bjerrum L, Søgaard J, Hallas J, Kragstrup J. Polypharmacy: correlations with sex, age and drug regimen. A prescription database study. Eur J Clin Pharmacol 1998; 54: 197-202.
7. Halkin H, Katzir I, Kurman I, Jan J, Malkin B. Preventing drug interactions by online prescription screening in community pharmacies and medical practices. Clin Pharmacol Ther 2001; 69: 260-5.
8. Cahill JA. Responsibilities of physicians and pharmacists in preventing drug interactions. JAMA 2002; 287: 586-7.
9. Glassman PA, Simon B, Belpeiro P, Lanto A. Improving recognition of drug interactions: benefits and barriers to using automated drug alerts. Med Care 2002; 40: 1161-71.
10. Weideman RA, Bernstein IH, McKinney WP. Pharmacist recognition of potential drug interactions. Am J Health Syst Pharm 1999; 56: 1524-9.
11. Malone DC, Hutchins DS, Haupert H, Hansten P, Duncan B, Van Berger RC, et al. Assessment of potential drug-drug interactions with a prescription claims database. Am J Health-Syst Pharm 2005; 62: 1983-91.
12. Monane M, Matthias DM, Nagle BA, Kelly MA. Improving prescribing patterns for the elderly through an online drug utilization review intervention: a system linking the physician, pharmacist and computer. JAMA 1998; 280: 1249-52.
13. Magnus D, Rodgers S, Avery AJ. GP's views on computerized drug interaction alerts: questionnaire survey. J Clin Pharm Ther 2002; 27: 377-82.
14. Peterson JF, Bates DW. Preventable medication errors: identifying and eliminating serious drug interactions. J Am Pharm Assoc 2001; 41: 156-60.
15. Peral Agirregoitia J, Lertxundi Etxebarria U, Martínez-Bengoechea MJ, Ibarra Barrueta O, Corcóstegui Santiago B, Mora Atorrasagasti O. Puesta en marcha de un sistema automatizado de monitorización de interacciones. Comunicación póster en el 50 Congreso de la Sociedad Española de Farmacia Hospitalaria. Oviedo. 2005. Farm Hosp 2005; 29(ext.1): 40.
16. Hansten PD, Horn JR. Hansten and Horn's Drug Interactions Analysis and management. St. Louis, MO: Facts and Comparisons; 2001 and updates.
17. Peng CC, Glassman PA, Marks IR, Fowler C, Castiglione B, Good CB. Retrospective drug utilization review: incidence of clinically relevant potential drug-drug interactions in a large ambulatory population. J Managed Care Pharm 2003; 9: 513-22.
18. Egger SS, Drewe J, Schlienger RG. Potencial drug-drug interactions in the medication of medical patients at hospital discharge. Eur J Clin Pharmacol 2003; 58: 773-8.
19. Micromedex® Healthcare Series (electronic version). Thomson Micromedex, Greenwood Village, Colorado, USA. Available at: http://www. thomsonhc.com (cited: 11/09/2006).
20. nd ed. Ohio: Lexi-comp; 2004.
21. Bergk V, Gasse C, Rothenbacher D, Loew M, Brenner H, Haeffeli WE. Drug interactions in primary care: Impact of a new algorithm on risk determination. Clin Pharmacol Ther 2004; 76: 85-96.
22. Elanjian S, Gora ML, Symes LR. Methods used by pharmacy departments to identify drug interactions. Am J Hosp Pharm 1993; 50: 2546-9.
23. Chui MA, Rupp MT. Evaluation of online prospective DUR programs in community pharmacy practice. J Manag Care Pharm 2000; 6: 27-32.
24. Cavuto NJ, Woosley RL, Sale M. Pharmacies and prevention of potentially fatal drug interactions. JAMA 1996; 275: 1086.
25. Bates DW, Cullen DJ, Laird N. Incidence of adverse drug events and potential adverse drug events. JAMA 1995; 274: 29-34.
26. Egger T, Dormann H, Ahne G, Runge U, Azaz-Livshits T, Neubert A, et al. Identification of adverse drug reactions in geriatric inpatients using a computerised drug database. Drugs Aging 2003; 20: 769-76.
27. García Batlle C, Pla Poblador R. Revisión de interacciones farmacológicas en un Hospital General. Farm Hosp 2002; 26: 110-8.
28. Abookire SA, Teich JM, Sandige H, Paterno MD, Martin MT, Kuperman GJ, et al. Improving allergy alerting in a computerized physician order entry system. Proc AMIA Symp 2000: 2-6.
29. Van der Sijs H, Aarts J, Vulto A, Berg M. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc 2006; 13: 138-47.
30. Raschke RA, Gollihare B, Wunderlich TA, Guidry JR, Leibowitz AI, Peirce JC, et al. A computer alert system to prevent injury from adverse drug events: development and evaluation in a community teaching hospital. JAMA 1998; 280: 1317-20.
31. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. JAMA 1998; 279: 1200-5.